Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado have entered a large-scale research collaboration in the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system. The Regeneron Genetics Center (RGC) will sequence these samples, producing genomic data that can be used to facilita...